No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
PTCT PTC Therapeutics
- 46.240
- +0.990+2.19%
Close Dec 20 16:00 ET
- 46.240
- 0.0000.00%
Post 16:15 ET
3.57BMarket Cap-7.78P/E (TTM)
47.420High44.740Low1.43MVolume44.770Open45.250Pre Close66.13MTurnover2.36%Turnover RatioLossP/E (Static)77.13MShares54.16052wk High-3.38P/B2.81BFloat Cap23.58052wk Low--Dividend TTM60.71MShs Float78.720Historical High--Div YieldTTM5.92%Amplitude4.030Historical Low46.191Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
J.P. Morgan's Top Healthcare Stocks for 2025
Express News | PTC Therapeutics Inc: PTC's Fourth Approval Application Submitted to FDA in 2024
Express News | PTC Therapeutics Announces Vatiquinone Nda Submission to FDA for the Treatment of Children and Adults Living With Friedreich Ataxia
PTC Therapeutics Announces Vatiquinone NDA Submission to FDA for the Treatment of Children and Adults Living With Friedreich Ataxia
Express News | PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Heat List
US
Overall
Symbol
Price
% Chg
No Data